Tardive dyskinesia: Analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America
Authors:
- Siegfried KasperSKSiegfried Kasper
- Amanda J. LowryALAmanda J. Lowry
- Andrew HodgeAHAndrew Hodge
- Istvan BitterIBIstvan Bitter
- Martin DossenbachMDMartin Dossenbach
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 81 (2-3) , 139-143
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effectiveness of Antipsychotic Treatments for SchizophreniaThe Journal of Clinical Psychiatry, 2004
- Developments in the pharmacological treatment of schizophreniaExpert Opinion on Investigational Drugs, 2002
- Extrapyramidal side effects are unacceptableEuropean Neuropsychopharmacology, 2001
- Tardive dyskinesia and atypical antipsychotic drugsSchizophrenia Research, 1999
- Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidolThe British Journal of Psychiatry, 1999
- Treatment of Tardive DyskinesiaSchizophrenia Bulletin, 1997
- SchizophreniaNew England Journal of Medicine, 1996
- Neuroleptic Withdrawal in Schizophrenic PatientsArchives of General Psychiatry, 1995
- Tardive Dyskinesia Outcomes: Clinical and Pharmacologic Correlates of Remission and PersistenceNeuropsychopharmacology, 1993
- The Prevalence of Tardive Dyskinesia in Neuroleptic-Treated DiabeticsArchives of General Psychiatry, 1991